AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells

Background: Chemotherapy is typically used to treat choriocarcinoma, but a small proportion of tumors develop resistance to chemotherapy. Similarly, methotrexate (MTX) is a first-line chemotherapy used to treat choriocarcinoma; although ~30% of patients are drug-resistant for MTX mono-therapy. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Xiang, Yang, Xiao, Changji, Guo, Peng, Wang, Dan, Liu, Ying, Shen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147634/
https://www.ncbi.nlm.nih.gov/pubmed/25170291
http://dx.doi.org/10.7150/ijms.9239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147634/
https://www.ncbi.nlm.nih.gov/pubmed/25170291
http://dx.doi.org/10.7150/ijms.9239

Ejemplares similares